Patients n = 356 |  |
---|---|
Female (%) | 79.8% |
Age (years) | 59.9 ± 12.7 |
Disease duration (years) | 11.5 ± 10.2 |
Rheumatoid factor positive(%) | 59% |
C-reactive protein (mg/dl) | 2.1 |
Erythrocyte sedimentation rate (mm/hour) | 25.9 ± 21.9 |
Swollen-joint count 28 | 2.1 ± 3.0 |
Tender-joint count 28 | 2.1 ± 3.8 |
Visual analogue scale pain (mm) | 28.0 ± 22.4 |
Patient global assessment of disease activity (mm) | 30.0 ± 23.3 |
Evaluator global assessment of disease activity (mm) | 11.0 ± 13.7 |
Clinical disease activity index | 8.3 ± 7.3 |
Simplified disease activity index | 9.1 ± 7.7 |
Disease activity score 28 | 3.2 ± 1.2 |
Health-assessment questionnaire | 0.81 ± 0.76 |
Euro QolL5D | 0.77 ± 0.19 |
Physical component score SF-36 | 37.6 ± 11.3 |
Mental component score SF-36 | 48.0 ± 12.0 |
Patients currently employed (%) | 26.5% |
Activity impairment due to problem (%) | 35.9 ± 26.7 |
Work time missed due to RA (%) | 7.7 ± 24.5 |
Impairment while working due to problem (%) | 27.8 ± 26.8 |
Overall work impairment due to RA (%) | 2.7 ± 10.5 |